Correlation Between Lexicon Pharmaceuticals and Seer
Can any of the company-specific risk be diversified away by investing in both Lexicon Pharmaceuticals and Seer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lexicon Pharmaceuticals and Seer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lexicon Pharmaceuticals and Seer Inc, you can compare the effects of market volatilities on Lexicon Pharmaceuticals and Seer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lexicon Pharmaceuticals with a short position of Seer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lexicon Pharmaceuticals and Seer.
Diversification Opportunities for Lexicon Pharmaceuticals and Seer
-0.89 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Lexicon and Seer is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Lexicon Pharmaceuticals and Seer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seer Inc and Lexicon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lexicon Pharmaceuticals are associated (or correlated) with Seer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seer Inc has no effect on the direction of Lexicon Pharmaceuticals i.e., Lexicon Pharmaceuticals and Seer go up and down completely randomly.
Pair Corralation between Lexicon Pharmaceuticals and Seer
Given the investment horizon of 90 days Lexicon Pharmaceuticals is expected to under-perform the Seer. In addition to that, Lexicon Pharmaceuticals is 2.75 times more volatile than Seer Inc. It trades about -0.11 of its total potential returns per unit of risk. Seer Inc is currently generating about 0.15 per unit of volatility. If you would invest 194.00 in Seer Inc on October 8, 2024 and sell it today you would earn a total of 53.00 from holding Seer Inc or generate 27.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Lexicon Pharmaceuticals vs. Seer Inc
Performance |
Timeline |
Lexicon Pharmaceuticals |
Seer Inc |
Lexicon Pharmaceuticals and Seer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lexicon Pharmaceuticals and Seer
The main advantage of trading using opposite Lexicon Pharmaceuticals and Seer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lexicon Pharmaceuticals position performs unexpectedly, Seer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seer will offset losses from the drop in Seer's long position.Lexicon Pharmaceuticals vs. BioLineRx | Lexicon Pharmaceuticals vs. Ardelyx | Lexicon Pharmaceuticals vs. Seres Therapeutics | Lexicon Pharmaceuticals vs. Immunitybio |
Seer vs. Oric Pharmaceuticals | Seer vs. Anebulo Pharmaceuticals | Seer vs. Cullinan Oncology LLC | Seer vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |